Next Steps for Implementing Quality Management of Clinical Investigations

This panel discussion session focuses on determining what the immediate next steps are for sponsors, CROs and other interested parties to incorporate quality management into clinical studies. Panelists identify best practices and needs that will facilitate increased adoption of quality management by interested parties presently and in the near future.
Panelists:
• Danilo Branco, Fortrea
• Michael Torok, Genentech
• Kelsie Pearson, Seattle Children’s Hospital (Cystic Fibrosis Foundation)
• Peter Stein, US Food and Drug Administration